Twist Bioscience (TWST)
(Delayed Data from NSDQ)
$27.52 USD
-2.69 (-8.90%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $27.81 +0.29 (1.05%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TWST 27.52 -2.69(-8.90%)
Will TWST be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TWST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TWST
Twist Bioscience (TWST) Reports Q3 Loss, Tops Revenue Estimates
Twist Bioscience (TWST) Reports Q2 Loss, Tops Revenue Estimates
TWST: What are Zacks experts saying now?
Zacks Private Portfolio Services
The Zacks Analyst Blog Highlights Illumina, BEAM, Twist Bioscience, Wave Life Sciences and CRISPR Therapeutics
Promising Genomics & Synthetic Biology Stocks to Consider in 2025
Twist Bioscience (TWST) Moves 6.6% Higher: Will This Strength Last?
Other News for TWST
Q3 2025 Twist Bioscience Corp Earnings Call Transcript
Cathie Wood's Ark Dumps Block Stock Worth $4.8 Million As Bitcoin-Heavy Company Preps Q2 Results
ARK Investment Makes Significant Purchase of Twist Bioscience (TWST)
Cathie Wood's ARK Investment buys 154.3K shares of Twist Bioscience today
Twist Bioscience Corp (TWST) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic ...